Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-11-17
DOI
10.1038/s41598-017-16499-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy
- (2017) Ning Yang et al. EXPERIMENTAL EYE RESEARCH
- The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice
- (2016) Laura M Hansen et al. LABORATORY INVESTIGATION
- Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema
- (2016) Hidetaka Noma et al. OPHTHALMIC RESEARCH
- Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
- (2015) Carmel M. McVicar et al. DIABETOLOGIA
- Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
- (2015) Khurrum Shahzad et al. KIDNEY INTERNATIONAL
- Increased Expression of Angiogenic and Inflammatory Proteins in the Vitreous of Patients with Ischemic Central Retinal Vein Occlusion
- (2015) Christoph Ehlken et al. PLoS One
- Galectin-1 induces vascular permeability through the neuropilin-1/vascular endothelial growth factor receptor-1 complex
- (2014) Ming-Heng Wu et al. ANGIOGENESIS
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes
- (2014) Xiaofei Chen et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Association of the TLR4 signaling pathway in the retina of streptozotocin-induced diabetic rats
- (2014) Yan-Ling Wang et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor γ Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products
- (2013) Ying Ju Chen et al. PLoS One
- Functional endothelial progenitor cells selectively recruit neurovascular protective monocyte-derived F4/80+/Ly6c+macrophages in a mouse model of retinal degeneration
- (2013) Shinichi Fukuda et al. STEM CELLS
- (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy
- (2012) A. Kanda et al. DIABETOLOGIA
- IL-1β Is Upregulated in the Diabetic Retina and Retinal Vessels: Cell-Specific Effect of High Glucose and IL-1β Autostimulation
- (2012) Yang Liu et al. PLoS One
- Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
- (2011) Ravichandran Ramasamy et al. Annals of the New York Academy of Sciences
- Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes
- (2011) A. S. Ibrahim et al. DIABETES
- Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells
- (2010) Xu-Yun Zhao et al. CARCINOGENESIS
- Para-inflammation in the aging retina
- (2009) Heping Xu et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Advanced Glycation End-Product of Low Density Lipoprotein Activates the Toll-Like 4 Receptor Pathway Implications for Diabetic Atherosclerosis
- (2008) Conrad P. Hodgkinson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started